Search

Your search keyword '"PLACENTAL growth factor"' showing total 6,592 results

Search Constraints

Start Over You searched for: Descriptor "PLACENTAL growth factor" Remove constraint Descriptor: "PLACENTAL growth factor"
6,592 results on '"PLACENTAL growth factor"'

Search Results

1. Targeting exercise-related genes and placental growth factor for therapeutic development in head and neck squamous cell carcinoma.

2. Maternal Thyroid Function and Biochemical Markers of Placental Function in Early Pregnancy.

3. Enhancing Pregnancy Care: Harnessing Label‐Free Immunosensors for Pre‐Eclampsia Detection Using PdNPs/Poly(3,5‐Diaminobenzoic Acid) Modified Glassy Carbon Electrodes.

4. Prediction of Fetal Death in Preterm Preeclampsia Using Fetal Sex, Placental Growth Factor and Gestational Age.

5. Effect of PLGF and EZH2 Expression in Placenta Tissue on GDM Placental Structure and Pregnancy Outcome.

6. Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study.

7. A Prospective Study on Risk Prediction of Preeclampsia Using Bi-Platform Calibration and Machine Learning.

8. Placental growth factor alleviates hyperglycemia‐induced trophoblast pyroptosis by regulating mitophagy.

9. Validation of the first‐trimester machine learning model for predicting pre‐eclampsia in an Asian population.

10. Utility of placental biomarkers and fetoplacental Dopplers in predicting likely placental pathology in early and late fetal growth restriction – A prospective study.

11. In vitro and in vivo effects of Galectin‐3 inhibitor TD139 on inflammation and ERK/JNK/p38 pathway in gestational diabetes mellitus.

12. Intermanufacturer assessment of diagnostic performance of angiogenic ratio vs glycosylated fibronectin in women with suspected pre‐eclampsia.

13. Discussion on the evaluation of the therapeutic efficacy of uterine artery blood flow parameters and serum PLGF and sFlt-1 in patients with recurrent spontaneous abortion.

14. Fibroblasts activation by embryonic signal switching: A novel mechanism of placental growth factor-induced cardiac remodeling.

15. B‐flow/spatiotemporal image correlation M‐mode ultrasound provides novel method to quantify spiral artery remodeling during normal human pregnancy.

16. Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo.

17. sFlt-1/PlGF ratio predicts serious outcomes in confirmed early-onset preeclampsia.

19. 胎盘生长因子预测子痫前期的研究进展.

20. Associations between first-trimester screening biomarkers and maternal characteristics with gestational diabetes mellitus in Chinese women.

21. Placental growth factor mediates pathological uterine angiogenesis by activating the NFAT5-SGK1 signaling axis in the endometrium: implications for preeclampsia development.

22. Placental expressions of Anti-Mullerian hormone/Receptor, vascular endothelial growth factor and related microRNAs in patients with preeclampsia: a case control study.

23. 三酰甘油, 氧化修饰低密度脂蛋白及胎盘生长因子与子痫前期病情进展 及其发生流产风险的关系研究.

24. Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up.

25. Plasma soluble fms‐like tyrosine kinase‐1, placental growth factor, and vascular endothelial growth factor system gene variants as predictors of survival in heart failure.

26. The value of angiogenetic biomarkers in the detection of early onset fetal growth restriction.

27. Maternal cardiovascular function in midgestation is related to placental angiogenesis.

28. Investigating hemolysis, elevated liver enzymes and low platelet count in preeclampsia: A case‐control study in Ghana.

29. Routine ante-natal screening using maternal risk factors and biomarkers for preeclampsia in 11-13+6 weeks of gestation

30. Maternal prediabetes as a risk factor of preeclampsia and placental dysfunction in pregnant female Sprague-Dawley rats.

31. Impact of physical activity on preeclampsia and angiogenic markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort.

32. Prioritisation of early pregnancy risk factors for stillbirth: An international multistakeholder modified e-Delphi consensus study.

33. Defining Gestational Thyroid Dysfunction Through Modified Nonpregnancy Reference Intervals: An Individual Participant Meta-analysis.

34. Maternal serum biomarkers of placental insufficiency at 24–28 weeks of pregnancy in relation to the risk of delivering small-for-gestational-age infant in Sylhet, Bangladesh: a prospective cohort study

35. Role of soluble fms-like tyrosine kinase-1/placental growth factor ratio along with uterine artery Doppler for the prediction of pre-eclampsia – A case–control study

36. The impact of yoga in pregnancy on placental growth factor levels and mean arterial pressure in pre-eclampsia: A randomized controlled trial

37. Bovine placental extracellular vesicles carry the fusogenic syncytin BERV-K1.

38. Biomarkers in the prediction of complications in pregnancy after assisted reproductive technology.

39. Placental Protein 13: Vasomodulatory Effects on Human Uterine Arteries and Potential Implications for Preeclampsia.

40. Diagnosis of pregnancy disorder in the first‐trimester patient plasma with Raman spectroscopy and protein analysis.

41. An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1.

42. A prediction model for stillbirth based on first trimester pre‐eclampsia combined screening.

43. Prediction of preeclampsia using maternal circulating mRNAs in early pregnancy.

44. Prediction of preterm birth in growth‐restricted and appropriate‐for‐gestational‐age infants using maternal PlGF and the sFlt‐1/PlGF ratio—A prospective study.

45. Revealing the molecular landscape of human placenta: a systematic review and meta-analysis of single-cell RNA sequencing studies.

46. Dysregulated placental expression of kynurenine pathway enzymes is associated with inflammation and depression in pregnancy.

47. Alpha 1,3 N-Acetylgalactosaminyl Transferase (GTA) Impairs Invasion Potential of Trophoblast Cells in Preeclampsia.

48. Palmitic acid impairs human and mouse placental function by inhibiting trophoblast autophagy through induction of acyl-coenzyme A-binding protein (ACBP) upregulation.

49. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta.

50. Urinary sFlt-1 and PlGF as preeclampsia predictors: sFlt-1/creatinine ratio improves the prediction value.

Catalog

Books, media, physical & digital resources